Reversing Inoperability in Eisenmenger Syndrome: The "Drug-and-Banding" Approach

World J Pediatr Congenit Heart Surg. 2020 Sep;11(5):646-648. doi: 10.1177/2150135120926977.

Abstract

Eisenmenger syndrome (ES) has been considered a cause of inoperability in patients with congenital heart disease (CHD). Even if long-standing vasodilators are efficient to reduce pulmonary vascular resistance (PVR), the best approach to grant stable repair of these patients is still unknown. We describe the case of a 28-year-old man with a diagnosis of untreated large ventricular septal defect and established ES. After few years of vasodilator therapy, the patient underwent pulmonary banding with significant reduction of his PVR. His CHD was then repaired, with clinical and functional improvement at 2-year follow-up.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cardiac Catheterization
  • Eisenmenger Complex / diagnosis
  • Eisenmenger Complex / physiopathology
  • Eisenmenger Complex / therapy*
  • Humans
  • Imaging, Three-Dimensional
  • Ligation
  • Male
  • Pulmonary Artery / surgery*
  • Tomography, X-Ray Computed
  • Vascular Resistance
  • Vasodilator Agents / therapeutic use*

Substances

  • Vasodilator Agents